News Silk Road Medical, Inc

Equities

SILK

US82710M1009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
17.8 ^USD	+0.85%		+2.24%	+45.07%

Apr. 02	Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus	CI
Mar. 08	North American Morning Briefing : Stock Futures -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference	Apr. 23	GL
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024	Apr. 09	GL
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS	Apr. 02	GL
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus	Apr. 02	CI
North American Morning Briefing : Stock Futures -2-	Mar. 08	DJ
Silk Road Medical Inc. and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products	Mar. 07	CI
Argus Upgrades Silk Road Medical to Buy From Hold, Price Target is $24	Mar. 07	MT
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System	Mar. 05	GL
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System	Mar. 05	AQ
Silk Road Medical Expands TCAR Portfolio with Launch of Tapered Enroute®? Transcarotid Stent System	Mar. 05	CI
Piper Sandler Raises Price Target on Silk Road Medical to $18 From $11, Maintains Neutral Rating	Feb. 29	MT
Silk Road Medical: Q4 Earnings Snapshot	Feb. 28	AQ
Transcript : Silk Road Medical, Inc, Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q4 Revenue $47.3M, vs. Street Est of $42M	Feb. 28	MT
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook	Feb. 28	GL
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024	Feb. 28	CI
Silk Road Medical, Inc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook	Feb. 28	AQ
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	Feb. 07	GL
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	Feb. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Silk Road Medical, Inc

Equities

SILK

US82710M1009

Summary

Filters